G. Schellong - Concepedia

Author

G. Schellong

Also Known As

G SCHELLONG, G Schellong, G. SCHELLONG, G. Schellong, G. Schellong, G. Schellong, Günther Schellong, GÜNther Schellong, Günther M. Schellong, Günther Schellong

193

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University Hospital Münster University of Münster Helios Hospital Berlin-Buch Uniwersytecki Szpital Dziecięcy Temple Street Children's University Hospital

About

G. Schellong is an author at University Hospital Münster specializing in medicine, pediatrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.3K
2	Public Health	3	3	263
3	Education	1	1	11
4	Health Sciences	1	1	64
5	Cell Biology	1	1	17

G. Schellong

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Alfred Reiter, Martin Schrappe, Wolfgang Ludwig, PubMed	2000	365
High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin's Disease: The German-Austrian Multicenter Trial DAL-HD-90 G. Schellong, Richard Pötter, Jürgen Brämswig, Journal of Clinical Oncology	1999	248
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials U. Creutzig, M Zimmermann, J. Ritter, Leukemia NeonatologyPediatric EpidemiologyPediatric HematologyClinical TrialsPediatrics	2005	228
The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence Jürgen Brämswig, Ulrike Heimes, Elisabeth Heiermann, Cancer SpermatogenesisFertilityReproductive HealthGynecologySemen Analysis	1990	172
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87 Ursula Creutzig, Jochen Harbott, Christian Sperling, Blood	1995	171
Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies G. Schellong, Marianne Riepenhausen, Christian Bruch, Pediatric Blood & Cancer	2010	171
Improved Treatment Results in Childhood Acute Myelogenous Leukemia: An Update of the German Cooperative Study AML-BFM-78 J. Ritter, U. Creutzig, Hansjörg Riehm, Hämatologie und Bluttransfusion Hematological MalignancyOncologyPediatric HematologyMixed-phenotype Acute LeukemiaHematology	1985	162
Definition of a standard‐risk group in children with AML Ursula Creutzig, M Zimmermann, J. Ritter, British Journal of Haematology	1999	153
Treatment of Children and Adolescents With Hodgkin Lymphoma Without Radiotherapy for Patients in Complete Remission After Chemotherapy: Final Results of the Multinational Trial GPOH-HD95 W Dörffel, U Rühl, H Lüders, Journal of Clinical Oncology	2013	141
Preliminary Results of the Multicenter Trial GPOH-HD 95 for the Treatment of Hodgkin’s Disease in Children and Adolescents: Analysis and Outlook W Dörffel, H Lüders, U Rühl, Klinische Pädiatrie	2003	139

Page 1